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Abstract
Purpose: To evaluate the utility of high-resolution, 3-D diffusion-weighted imaging (DWI) in the detection of breast 
cancer and to compare the sensitivity, specificity, and area under the curves of DWI and dynamic contrast-enhanced 
magnetic resonance imaging (DCE-MRI). 
Material and method: Prospective IEC approved study included 131 breast lesions detected on mammography and 
breast ultrasound. Cases underwent MRI on a 3 Tesla scanner using a dedicated breast coil. T2WI, STIR, T1WI, and 
dynamic post contrast MR. DWI MRI with b value of 50, 800, and 1500 s/mm2. Post-processing data with apparent 
diffusion coefficient (ADC) calculations and kinetic curves were obtained. Characteristics for lesions were analysed 
as per ACR BI-RADS descriptors. Final histopathological diagnosis was considered as the standard of reference.  
c2 test, t-test, receiver operating characteristic (ROC) curve analysis, pairwise comparison of ROC curves, sensitivity, 
specificity, diagnostic accuracy, and area under the curve (AUC) were calculated.
Results: Sixty-six (50.38%) malignant and 65 (59.62%) benign lesions were included in the study. The mean ADC 
of malignant lesions was 0.870 × 10–3 mm2/s and 1.637 × 10–3 mm2/s (p < 0.0001) for benign lesions. Sensitivity and 
specificity for DWI were 95.45% and 90.76%, respectively, and for DCE-MRI they were 96.97% and 87.69%, respec-
tively. Positive predictive value (PPV) and negative predictive value (NPV) were obtained at 91.30% and 95.16%, 
respectively, in DWI while in DCE-MRI they were 88.88% and 96.61%, respectively. The AUC for ADC was 0.979. 
In ROC comparison of AUC for DWI 0.931 and for DCE-MRI 0.923, the difference between the areas was 0.00781 
(p = 0.782).
Conclusions: High-resolution DWI is a non-contrast MRI technique, which improves the lesion detection with diag-
nostic performance comparable to DCE-MRI and has potential as an adjunct with screening mammography. 
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Introduction
Breast cancer is the most common cancer in women and 
the most frequent cause of mortality. In the United States, 
almost 12.4% (1 out of 8 women) of women are at lifetime 
risk of developing breast cancer, thus making it one of 
the most challenging issues in women’s health [1]. In de-
veloping countries, breast cancer is usually diagnosed at 
very late stages, and the rate of occurrence is expected to 
increase in the coming years, which warrants routine per-
formance of screening programs [2]. Since the introduc-
tion of the breast screening programme, it has involved 
conventional X-ray mammography; however, despite its 
benefits there are challenges due to the potential harm of 
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the radiation [3]. Additionally, false positive results (in 
≥ 50% cases) in unnecessary invasive procedures may lead 
to emotional distress in the patients [4,5].
Dynamic contrast-enhanced magnetic resonance 
imaging (DCE-MRI) is the most sensitive non-invasive 
investigation in the detection of breast carcinoma with 
high sensitivity, and it provides contrast-enhanced char-
acteristics of the lesion [6,7]. However, it is an arduous 
investigation and it requires contrast media. On the other 
hand, diffusion-weighted imaging (DWI) is a non-con-
trast technique, which derives image contrast from differ-
ences in the diffusion rate of water molecules in normal 
and pathological tissues. Malignant lesions usually have 
a higher degree of cellularity and they often demonstrate 
restriction on DWI. DWI can be interpreted both quanti-
tatively and qualitatively.
Studies revealed that DWI has promising utility to dis-
tinguish benign from malignant breast lesions with good 
sensitivity [7-9]. Breast DWI combined with DCE-MRI 
in the detection of breast carcinoma demonstrated high 
sensitivity and specificity [10,11]. However, there was sig-
nal noise from the background breast parenchyma, which 
decreases the sensitivity in smaller lesions. Increasing the 
b value increases background parenchymal suppres-
sion and hence gives better visibility of the lesion. Dense 
breast, which has a higher proportion of fibroglandular 
tissues, represents a high risk for breast cancer. Mammog-
raphy is less sensitive in dense breast parenchyma because 
smaller lesions can mask in the dense breast tissue. Hence, 
women with high breast density would benefit from DWI 
with background suppression technique. Moreover, one 
of the biggest safety concerns in recent years is the use of 
intravenous contrast agent [12]. As an alternative, studies 
are focusing on DWI with background suppression that 
can markedly enhance the contrast resolution between the 
malignant masses and the normal breast parenchymal tis-
sue [13,14]. DWI is the fast technique and can be done in 
free breathing [15].
Furthermore, the apparent diffusion coefficient (ADC) 
value can also be calculated using DWI. The ADC value 
is a quantitative measure, which is directly proportional 
to water diffusion, and it is helpful in differentiating ma-
lignant from benign lesions [8]. DWI can be obtained in 
thin sections, which further reformat and subsequently 
created as 3-D images like DCE-MRI. Therefore, the aim 
of this study was to evaluate the utility of high-resolution 
DWI to predict the likelihood of malignancy in breast le-
sions as compared with DCE-MRI. Towards this goal, the 
study will evaluate the qualitative analysis of DWI, ADC 
values in malignant and benign breast lesions, followed 
by the sensitivity and specificity analysis of DWI as well 
as DCE-MRI and their comparison. DWI technique is fast 
and non-invasive as compared to DCE-MR. In this study, 
DWI is evaluated and its utility is clinically investigated 
towards its implementation as an adjunct with screening 
mammograms in suspicious lesions. 
Material and methods
Study population 
This single-centre, prospective study was approved by the 
institutional review board and institutional ethics com-
mittee (Ref no. DYPV/EC/174/17). Written, informed 
consent was obtained from all the patients before MRI. 
The study included 116 female patients (mean age 40.37, 
age range 18-82 years) with suspected breast lesions de-
tected on mammography and/or breast ultrasound, or 
indeterminate diagnosis on mammography and/or ultra-
sound. Patients who had not undergone biopsy and were 
followed up by imaging were excluded from this study.
Inclusion criteria: 
1. Patient who detected suspicious mass lesions or inde-
terminate diagnosis on digital mammography and/or 
breast ultrasound (ACR BI-RADS 0, 3, 4, and 5).
2. Micro-calcification, architectural distortion, or focal 
asymmetry detected on digital mammography.
3. Women with a clinically palpable breast lump.
Exclusion criteria: 
1. Patients with known allergy to gadolinium-based con-
trast media, deranged renal function test, pregnant 
women.
2. Patients having cardiac pacemakers, cardiac valves, co-
chlear implants, or other metallic implants.
3. Patients from whom histopathology and clinical follow-
up were unavailable were excluded from the study.
Magnetic resonance imaging
Clinical and examination history was obtained from each 
patient. All MRI examination was performed prior to the 
biopsy of the detected breast lesion. All the cases under-
went MR examination on a 3T MRI scanner (MAGNE-
TOM Vida, Siemens Healthcare GmbH, Germany) us-
ing a dedicated 18-channel breast coil. MRI examination 
includes image acquisition followed by post processing. 
MRI examinations were performed in prone position 
without applying compression. However, foam was used 
to fix the breast adequately in the coil. Initially, a multi-
planer localizer was applied with a field of view (FOV) 
of 300-360 mm and slice thickness of 3 mm. For MR 
examination, the following sequences were used: non-
enhanced T1WI, T2WI, STIR, DWI, and dynamic post-
contrast MRI. The MR parameters used in DWI imaging 
(whole breast transverse orientation) are as follows: field 
of view (FOV) of 360 mm, slice thickness of 3 mm, rep 
time/echo time (TR/TE) of 6800/70 ms, matrix size of 
168 × 168, b1 value of 50 s/mm2, b2 value of 800 s/mm2, 
and b3 value of 1500 s/mm2. For short tau inversion re-
covery (STIR) MR imaging, the following parameters are 
used: FOV of 300 mm, slice thickness of 3 mm, TR/TE of 
3800/70 ms, matrix size of 448 × 448. T2-weighted im-
ages (whole breast transverse orientation) are acquired 
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with the following parameters: FOV of 320 mm, slice 
thickness of 3 mm, TR/TE of 3000/71, and matrix size of 
448 × 336. For pre-contrast, fat-suppressed T1-weighted 
images whole breast transverse orientation – 3D spectral 
adiabatic inversion recovery (SPAIR) – was applied with 
the following parameters: FOV of 320 mm, TR/TE of 
6.13/3.30 ms, and slice thickness of 0.8 mm. A dynamic 
post-gadolinium T1WI fat sat study was obtained in the 
transverse plane. Bolus of MultiHance (GdDTPA-BMA) 
0.1 mmol/kg body weight was injected with the help of 
a pressure injector with a flow rate of 2.0 ml/s. Post-con-
trast injection was followed by a flush of 20 ml of saline. 
Post-contrast fat-suppressed T1-weighted images were 
obtained in the whole breast transverse orientation in 
3D spectral adiabatic inversion recovery (SPAIR) with 
the following parameters: FOV of 320 mm, slice thick-
ness of 0.8 mm; TR/TE of 6.13/3.30 ms, and flip angle 
(FA) of 10°. Dynamic post-contrast study consists of 
1 pre-contrast T1-weighted fat sat imaging sequence and 
5 post-contrast series. 
Image interpretation and analysis
Post processing was performed on the MR vendor’s work-
station, a Syngo MR XA 11 A, equipped with post-pro-
cessing capabilities. Sequential post-contrast images were 
digitally subtracted from the pre-contrast images. Maxi-
mum intensity projection (MIP) was obtained through 
each orthogonal plane. Kinetic analysis of the enhancing 
lesions was obtained using the mean curve technique. 
DWI was analysed by an experienced radiologist and the 
ADC values of each suspected breast lesion were obtained 
on the workstation by drawing a manual region of interest 
(ROI). A b-value of 1500 s/mm2 was considered for the 
analysis of the DWI of each lesion.
Image analysis and interpretation performed by an 
expert radiologist having more than 15 years of breast 
imaging and 20 years of MRI experience. For the inter-
pretation of the MRI examination, analysis of the pre-
contrast sequences, dynamic post-contrast images, and 
the post-processing data were considered. Initially STIR, 
T2WI, and T1-weighted images were analysed to detect 
the presence of a lesion or cyst. Post-contrast enhance-
ment was analysed as foci enhancement, enhancing mass, 
or non-mass enhancement of the breast lesion. Assess-
ment of the morphologic characteristics of the lesion was 
also performed according to the shape, margins, and en-
hancement kinetics. Analysis of the enhancement kinetics 
of the breast lesion was obtained by the peak percentage 
of the lesion enhancement in the early post-contrast phase 
(wash in) and the shape of the curve after early phase en-
hancement (wash out). The type of kinetic curve was de-
fined by the delayed phase-enhancement pattern. When 
there was a continuous steady increase in the signal inten-
sity of the lesion throughout the entire dynamic phase, it 
was defined as a type I curve. The type II curve was like 
a plateau, which showed early enhancement but the signal 
intensity did not change in the delayed phase. The type III 
curve showed early enhancement and early washout in 
the delayed phase. It was obtained on the workstation 
by manually drawing the region of interest (ROI) on the 
enhanced lesion. The area of the necrosis and the partial 
volume effect in the margins of the lesion due to the ad-
jacent parenchyma were avoided for the selection of ROI. 
In DCE-MRI, criteria to distinguish malignant and be-
nign breast lesions were based on the morphology and 
enhancement kinetics according to the American College 
of Radiology BI-RADS lexicon 5th edition. All the calcula-
tions were done on each breast lesion. To obtain the sensi-
tivity and specificity for DCE-MRI, the assigned BI-RADS 
category according to the ACR BI-RADS lexicon 5th edi-
tion were considered.
DWI analysis: Lesions showing bright signals on 
DWI with corresponding low ADC values were consid-
ered positive for malignancy as qualitative DWI analysis. 
For DWI analysis, a ROI was manually drawn on the le-
sion that showed the brightest signal on DWI with corre-
sponding ADC images. ADC values were obtained from 
all the lesions showing either restriction or no restriction. 
Areas of necrosis were avoided for the selection of ROI. 
Mean ADC values were taken as quantitative analysis of 
DWI. DWI signal intensity of each lesion was observed as 
high, equal or low compared to background parenchyma. 
The lesions that showed diffusion restriction with cor-
responding low ADC values were considered positive 
whereas lesions that did not show restriction were con-
sidered as benign lesions.
Based on scoring, lesions having category 1 and 2 were 
considered benign lesions, and category 4 and 5 were 
considered as positive lesions for suspicious malignancy. 
BI-RADS 2 lesions in the study that had undergone tissue 
diagnosis were either high-risk patients, when patient had 
BI-RADS 4 or 5 lesions in the contralateral or ipsilateral 
breast, or excision of the benign pathology was performed 
due to large size, depending on the patient’s preference. 
BI-RADS 2 and 3 lesions that were not biopsied and fol-
lowed up by imaging were excluded from the study. Final 
histopathological diagnosis obtained by needle biopsy, 
lumpectomy, or mastectomy was considered as the stan-
dard of reference.
Statistical analysis
Statistical analysis was performed using MedCalc Statisti-
cal Software bv, Ostend, Belgium Version 19.3.1. All the 
calculations were obtained on a per lesion basis. The in-
dependent t-test was applied for the normally distributed 
continuous variables to obtain the mean, average, and 
standard deviation values. Pearson’s c2 test was applied 
for non-normally distributed or categorical variables. Re-
ceiver operating characteristic (ROC) curves were plotted 
to calculate the area under the curve for the mean ADC 
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values and dynamic contrast enhanced semi-quantitative 
kinetic curve analysis for each lesion. Statistical differenc-
es between areas under the curve were analysed by using 
the method proposed by Hanley and McNeil [16]. Cut-
off values were obtained with the method of maximizing 
the Youden index (sensitivity + specificity – 1). Diagnostic 
sensitivity, specificity, and accuracy were calculated using 
the ADC cut-off value. The confidence interval for pre-
cision analysis was calculated to achieve the precision of 
0.05 for the 95% confidence interval for the diagnostic 
indexes. Diagnostic indexes were calculated with 95% 
confidence intervals for sensitivity, specificity, positive 
predictive value (PPV), negative predictive value (NPV), 
and AUC for the MRI findings using DWI and dynamic 
contrast-enhanced magnetic resonance (CEMR) tech-
niques. A two-sided p value of <0.05 was considered as 
a statistically significant difference in the analysis. ROC 
curve comparison was performed for 2 parameters: DWI 
and DCE-MRI, as well as ADC and semi-quantitative 
kinetic curves. Differences in the area under the curves 
were obtained using the method proposed by Hanley and 
McNeil [16].
Results
The study included 116 patients with 131 breast lesions, 
with an age range of 18-82 years (mean age 40.37 ± 14.34 
years). In the final histopathology diagnosis of breast 
lesions, 66 (50.38%) of all cases were malignant and 65 
(49.62%) were benign lesions. The mean age of the women 
who constituted the malignant lesions was 47.73 ± 14.06 
years. There were 117 mass lesions and 14 non-mass le-
sions in the study. 
DWI: The smallest size of lesion, which was detected 
with DWI, was 4 mm, and the largest size the lesion was 
80 mm; the mean size was 24.10 mm (± 15.43). In 131 le-
sions, 69 (52.7%) appeared as malignant and 62 (47.3%) 
were benign on DWI. Ten patients had multiple lesions 
n = 7 (malignant), n = 3 (benign). The most common 
malignant lesion was invasive ductal carcinoma, seen in 
43 (65.2%) cases (Table 1). The most common benign 
pathology was fibroadenoma, detected in 22 (33.84%) 
cases. Malignant lesions showed high signal intensity on 
DWI with corresponding low ADC values (Figure 1). 
Benign lesions did not show restriction on DWI and 
showed high ADC values, as depicted in Figure 2. 
The diagnostic performance of DWI (qualitative and quan-
titative) is shown in Table 2. The mean ADCs of malignant 
lesions was 0.870 ± 0.129 × 10–3 mm2/s and benign lesions 
was 1.637 ± 0.469 × 10–3 mm2/s (p < 0.0001) (depicted in 
box and whisker plot in Figure 3). The ROC curve of ADC 
was plotted, which showed the area under the curve as 
0.979 with a p-value < 0.001 (significant), as shown in Fig-
ure 4A. The cut-off value of ADC was 1.003 × 10–3 mm2/s 
to achieve the sensitivity of 89.39% and specificity 98.46%, 
to discriminate between the malignant and benign breast 
lesions.
DCE-MRI: For DCE-MRI analysis, lesions were ob-
served for the enhancement pattern and time signal in-
tensity curves were obtained by manually drawing ROI 
on the area, which showed the strongest enhancement, 
identified on first contrast subtracted images. Type I ki-
netic curve was seen in 31.3% (n = 41, 39 benign and 
2 malignant), type II curve in 29.8% (n = 39, 23 benign 
and 16 malignant), and type III curve was observed in 
38.9% (n = 51, 48 malignant and 3 benign) of lesions. 
DCE-MRI correctly diagnosed 56 malignant cases, but 
in 6 cases it showed false positive results and in 2 cases 
false negative results. Sensitivity, specificity, and diag-
nostic accuracy of the DCE- MRI shown in Table 2. 
The ROC curve was plotted for the semiquantitative ki-
netic curves values of breast lesions shown on the DCE-
MRI study (Figure 4B), which showed an area under 
the curve (AUC) of 0.908 with sensitivity of 72.73% and 
specificity of 95.38%. 
The ROC comparison was performed using the Han-
ley and McNeil method, which demonstrated an AUC 
for DWI (quantitative and qualitative) of 0.931, and for 
DCE MRI (kinetics and morphology) it was 0.923; the 
difference between the areas was 0.00781, which was not 
significant (p = 0.782) (Figure 5A). 
The ROC comparison of variables using semi-quanti-
tative (kinetic curves) DCE-MRI (AUC = 908) and ADC 
(AUC = 0.979) was also plotted, as shown in Figure 5B. 
Comparative analysis of the variables using DCE-MRI ki-










DCIS 11 (16.66) Fibrocystic changes 9 (13.84)
Invasive lobular 
carcinoma
4 (6.06) Adenosis 5 (7.70)
Mucinous 
carcinoma
1 (1.50) Infective 
pathology/Abscess
7 (10.76)





4 (6.06) Benign phyllodes 5 (7.70)
Angiosarcoma 1 (1.50) Papilloma 3 (4.61)
Ductal hyperplasia 4 (6.15)
Epithelial atypia 3 (4.61)
Tubular adenoma 1 (1.53)
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netic curves, ADC values for DWI, qualitative and quanti-
tative analysis of DWI and DCE-MRI (kinetics and mor-
phology analysis) are shown in Table 3.
Discussion
In this study we found that a DWI with an increased 
b value demonstrates significantly higher image quality 
and lesion visibility with background breast parenchymal 
suppression. When diffusion-weighted echo-planar imag-
ing sensitizing diffusion gradients with a high b value of 
1500 s/mm2 were applied, it failed to visualise the non-
specific lesions that are commonly seen with lower b val-
ues [17-19]. Previous studies were done of the effectivity 
of the DWI in malignant lesions of breast; however, they 
did not compare the result separately with DCE-MRI. In 
our study the result of DWI and DCE-MRI was compa-
rable. The lesions were effectively detected on DWI im-
ages; even the skin changes, nipple involvement, axil-
lary lymph nodes involvement, and local invasion were 
observed effectively. In the cases of multiple lesions, the 
numbers of all the lesions were comparable to the dy-
namic CEMR study result. On 3D reconstructive images, 
lesion localization was accurately performed (Figures 1 
and 2). Using multivariate analysis along with low ADC 
values was the most significant independent predictor of 
the malignancy, and it was more sensitive when we ef-
fectively suppressed the background parenchymal signals. 
The overall diagnostic accuracy of the DWI with high 
b values with background suppression was comparable to 
the dynamic post-contrast MRI of the breast in our study. 
In this study a few small lesions of 4-5 mm were also ac-
curately detected as malignant; however, this depends on 
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Figure 1. Magnetic resonance imaging (MRI) of a 34-year-old woman 
shows invasive ductal carcinoma mass in the right breast (arrow). A) Axial 
diffusion-weighted imaging (DWI) with black/white inversion shows the 
malignant lesion (arrow) as a focal area of diffusion restriction. B) Corre-
sponding low apparent diffusion coefficient (ADC) in the malignant lesion of 
0.810 × 10–3 mm2/s. C) Sagittal view DWI. D) Axial contrast-enhanced MRI 
shows an irregular mass with heterogeneous post-contrast enhancement 
(arrow). E) Lesion shows type III kinetic curve on dynamic contrast-en-






Pratiksha Yadav, Saumya Harit, Dileep Kumar  
e282 © Pol J Radiol 2021; 86: e277-e286
lution. Previous studies demonstrated that the combined 
use of DWI and DCE-MRI improves the sensitivity and 
specificity of the breast carcinoma examination [10,11]. 
The purpose of our study was to evaluate the utility of 
high-resolution 3-D DWI in the detection and differ-
entiation of benign and malignant breast lesions and to 
compare its performance with dynamic contrast MRI 
study. There were two false negative lesions on DCE-MRI, 
A
Figure 2. Fibroadenoma in a 42-year-old woman in the upper outer quadrant of left breast. A) Axial diffusion-weighted imaging (DWI) with black/white 
inversion shows a lesion that did not show restriction on DWI (arrow) and shows similar signal intensity as background parenchyma. B) The benign lesion 
shows corresponding high apparent diffusion coefficient (ADC) (arrow) of 1.43 × 10–3 mm2/s. C) Dynamic contrast-enhanced magnetic resonance imaging 



















Table 2. Comparison of diagnostic parameters using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)
Result DCE-MRI (%) DWI (%)
Sensitivity 96.97 (95% CI: 89.47-99.63) 95.45 (95% CI: 87.28-99.05)
Specificity 87.69 (95% CI: 77.18-94.53) 90.76 (95% CI: 80.98-96.53)
PPV 88.88 (95% CI: 80.67-93.87) 91.30 (95% CI: 83.02-95.75)
NPV 96.61 (95% CI: 87.89-99.11) 94.16 (95% CI: 86.65-98.34)
Diagnostic accuracy 92.37% (86.41-96.28%) 93.13% (87.36-96.81%)
AUC 0.923 (0.864-0.963) 0.931 (0.873-0.968)
Data in parentheses are 95% confidence intervals. PPV – positive predictive value, NPV – negative predictive value, AUC – area under the curve
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Figure 3. Box and whisker plot shows the relationship between the appar-








































Figure 4. Receiver operating characteristic (ROC) curves of variables of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic reso-
nance imaging (DCE-MRI). A) ROC of apparent diffusion coefficient (ADC) values shows area under the curve = 0.979. B) ROC of kinetic curves of DCE-MRI 
of various breast lesions shows area under the curve 0.908
A B
both were of low-grade DCIS and not showed contrast 
enhancement. One case of low-grade ductal invasive car-
cinoma and two cases of DCIS has shown false negative 
results on DWI. DCE-MRI showed eight false positives 
(two mastitis, one tubular adenoma, one fibroadenoma, 
one phyllodes, one sclerosing adenosis and two papillo-
mas), however DWI showed six false positives (one tu-
bular adenoma, two mastitis and two sclerosing adenosis 
and one phyllodes) showed false positive results in this 
study. Sclerosing adenosis, tubular adenoma, mastitis and 
phyllodes cases showed false positive results in both DCE-
MRI and DWI.
High-resolution DWI with high b value parameter re-
sult shows sensitivity of 95.45% and specificity of 90.76% 
which matches with the study done by Bickelhaupt 
et al. [13]. In their study, sensitivity was 0.92 and specific-
ity was 0.94. In our study sensitivity of dynamic CEMR 
was 96.97% and specificity 87.69%. Pereira et al. studied 
the utility of DWI in differentiating benign from malig-
nant breast lesions by assessing the best b value. They 
concluded that all the b value combinations showed high 
sensitivity to differentiate benign from malignant le-
sions. The mean ADC obtained from malignant breast 
lesions (0.68-1.25 ± 0.25-0.28 × 10-3 mm2/s) was signifi-
cantly lower than the benign lesions (1.44-1.77 ± 0.31-0.44 
× 10–3 mm2/s) in all b value combinations [14]. Spick et al. 
concluded that additional application of DWI in breast le-
sions could avoid false positive, MR-guided biopsies [20]. 
They found that the mean ADC values were 1.53 ± 0.38 
× 10-3 mm2/s in benign lesions and 1.06 ± 0.27 × 10-3 mm2/s 
in malignant lesions [20]. In our study was the mean ADC 
value was significantly lower in malignant lesions (0.870 
± 0.129 × 10–3 mm2/s) than the benign lesions (1.637 
± 0.469 × 10–3 mm2/s) and these were in agreement with 
previous studies. ROC evaluation in a study by Spick 
et al. revealed benign lesions if the ADC value was more 
than 1.58 × 10-3 mm2/s [20]. In our study the cut-off value 
of ADC was 1.003 × 10–3 mm2/s to achieve the sensitivity 
of 89.39% and specificity 98.46% to discriminate between 
the malignant and benign breast lesions.
Chen et al. conducted a meta-analysis of the diagnos-
tic performance of quantitative diffusion-weighted MR 
imaging in breast lesions. In this work it was observed that 
the mean ADC values of the benign lesions ranged from 
1.00 to 1.82 × 10-3 mm2/s and in malignant lesions from 
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Figure 5. Comparative receiver operating characteristic (ROC) curve analysis. A) Comparison of ROC of apparent diffusion coefficient (ADC) values and 
kinetic curve analysis shows difference between areas 0.716 (p = 0.0062). B) Comparison of ROC of diffusion-weighted imaging (DWI) and dynamic con-
trast-enhanced magnetic resonance imaging (DCE-MRI) findings of various benign and malignant breast lesions shows difference between areas 0.00781 
(p = 0.782)




























0.87 to 1.36 × 10-3 mm2/s. Cut-off values that differentiate 
benign and malignant breast lesions ranged from 0.90 to 
1.76 × 10-3 mm2/s in their study while the sensitivity and 
specificity ranged from 63% to 100% and 46% to 97%, 
respectively [21].
Stadlbauer et al. evaluated the efficacy of diffusion-
weighted MR imaging with background suppression 
(DWIBS) and conventional DWI (cDWI) for the detec-
tion of breast lesions [17]. In their study, 36 lesions were 
detected in 30 patients. DWIBS detected 34 lesions (94%) 
and cDWI detected 26 lesions (72%). They concluded 
that DWIBS is superior to cDWI in the visualization of 
malignant and benign lesions of the breast [17]. In their 
study they found that the overall NPV of DWIBS was 
0.92; in our study NPV of high-resolution DWI it was 
0.95. They found the accuracy in detection of invasive 
ductal carcinoma to be high in their study. For invasive 
ductal carcinoma NPV was higher in our study, which 
gave a false negative only in one case of invasive ductal 
carcinoma.
Jiang et al. used automated segmentation and features 
extracted from DCE-MRI and DWI to discriminate ma-
lignant and benign masses, and they concluded that in-
corporating morphology and texture features, ADC, and 
kinetic features increases the diagnostic accuracy of the 
MRI breast examination [22].
Pinker et al. performed multi-parametric MRI using 
CEMR, DWI, and magnetic resonance spectroscopy in 
breast lesions, and they concluded that multi-parametric 
MRI with 3 parameters: DCE, DWI, and MRS, showed 
the highest sensitivity of 100% and the positive predictive 
value was 93.7% [23].
DWI reduced the examination as well as the reading 
time, and it was useful as an adjunct to mammography in 
our study. Although in this study pregnant women were not 
included, DWI with high b value with background paren-
chymal suppression may be promising in terms of generat-
ing good diagnostic performance in younger women and 
even in pregnant women because it is a non-radiation tech-
nique. We propose that this technique be used in the screen-
ing protocol as an adjunct to mammography, especially in 
dense breast parenchyma and in suspicious lesions detected 
on mammography or ultrasound. The DWI sequence is only 
around 5 minutes long and non-contrast, which can be used 
as an economic investigation. This technique is useful in 
revealing the false positive cases on mammography before 
biopsy, with a negative predictive value of 94.16%. 
The limitations of the study were that it was prospec-
tive in nature, was conducted in a single institute, and on 
a small number of cases. We aim to confirm our prelimi-
nary findings on a larger number of subjects. Inter-observer 
and intra-observer variability were not considered in this 
study. Prior to widespread adoption of DWI for tumour 
assessment, multi-centre trials are required to validate these 
findings. Detection of smaller lesions (< 5 mm) remains 
challenging with DWI due to limited spatial resolution. 
Conclusions
High-resolution diffusion-weighted MRI is a good non-
contrast, non-radiation, non-invasive, and fast technique, 
which has the potential to efficiently discriminate breast 
carcinoma from benign breast lesions. It is feasible and can 
be obtained in free breathing with better lesion visibility. 
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Table 3. Pairwise comparison of receiver operating characteristic (ROC) curves
Variable AUC SE 95% CI
DCE-MRI 0.923 0.0270 0.864-0.963
DWI 0.931 0.0257 0.873-0.968
ADC 0.979 0.0112 0.938-0.996
CEMR (semiquantitative) 0.908 0.0263 0.845-0.951
DCE-MRI ~ DWI
Difference between areas 0.00781
Standard errora 0.0283
95% Confidence interval –0.0476 to 0.0632
Significance level p = 0.7822
DCE-MRI ~ ADC
Difference between areas 0.0562
Standard errora 0.0264
95% Confidence interval 0.00441 to 0.108
Significance level p = 0.0334
DWI (qualitative) ~ ADC
Difference between areas 0.0484
Standard errora 0.0251
95% Confidence interval –0.000753 to 0.0975
Significance level p = 0.0536
CEMR (semiquantitative) ~ ADC
Difference between areas 0.0716
Standard errora 0.0261
95% Confidence interval 0.0204 to 0.123
Significance level p = 0.0062
aHanley and McNeil, 1982. AUC – area under the curve, DCE-MRI – dynamic contrast-enhanced magnetic resonance imaging, DWI – diffu-
sion-weighted imaging, ADC – apparent diffusion coefficient, CEMR – contrast-enhanced magnetic resonance
It can be useful in breast cancer screening in dense breasts 
with inconclusive mammograms. It has the potential to be 
used as an adjunct with mammography in the screening of 
breast lesions to detect malignancies with more confidence, 
and it may reduce the number of biopsies. 
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